Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis

Date: January 11, 2021 Issue #:  1615Summary:  The FDA has approvedGimoti (Evoke), a nasal spray formulation of the dopamine-2 (D2) receptor antagonist metoclopramide, for relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Metoclopramide (Reglan, and generics) has been available for years in conventional and orally-disintegrating tablets and in an injectable formulation. It is the only drug that is FDA-approved for treatment of diabetic gastroparesis.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Antibacterials Azithromycin diabetic gastroparesis Domperidone Erythromycin Gimoti Metoclopramide Motilium ondansetron Promethazine Reglan Scopolamine Source Type: research